about
Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedTriple reuptake inhibitors: the next generation of antidepressantsTriple Reuptake Inhibitors: A Premise and PromiseBehavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapySynergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India.Antidepressant-induced hepatotoxicity.Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.Chronic clomipramine treatment reverses core symptom of depression in subordinate tree shrewsSSRI discontinuation syndrome. Awareness as an approach to prevention.Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.Comorbidities in chronic neuropathic pain.Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.Wfs1-deficient mice display altered function of serotonergic system and increased behavioral response to antidepressantsFuture applications of high-resolution MS to meet the demands for pain management drug testing.Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice.Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration.Development and Characterization of Novel Floating-Mucoadhesive Tablets Bearing Venlafaxine Hydrochloride.Sertraline for social anxiety disorder.Enantiopurity determination of the enantiomers of the triple reuptake inhibitor indatraline.Anticholinergic-type effects following a pediatric venlafaxine overdose.Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.Prolonged post-dural puncture headache in a patient during treatment with selective serotonin reuptake inhibitor: a case report and animal experiment.Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine.Early Life Stress, Depression And Parkinson's Disease: A New Approach.Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM).
P2860
Q24564967-71E2DB55-1160-489C-BE6A-5DEEB77D9168Q24658248-8292E1A2-EB61-4F67-96E8-54192F8F6445Q28972234-2B6CEA3A-6023-47C6-8436-9B08BB733897Q30580754-40A4EF29-AB79-45D9-99C2-5DD1DDD48A4CQ31121208-18418684-AA47-4FB4-B340-3BE89EB42C9AQ33718185-DFDC808D-1F36-48D8-9908-10DE8BC15264Q33884174-7973186E-D77B-47B6-B051-13442F9DFA7FQ34177643-80C2AB87-0A68-400B-B160-4AEAAE507D32Q34247684-21BFC99E-01DC-4CAD-AE6A-2A8358729674Q34536009-479BD7E8-7589-4AE1-AC11-7A245BE7ABC7Q34707570-C93B08C9-A0CF-4A7C-AA0A-A7E27619C309Q35061145-3AF44DC3-E925-4F3E-A008-72AA54AB9ED7Q35202596-A1F6E376-BF25-42DF-B841-C7DD39923DA0Q35629744-3EC111BC-589A-42F1-A4FD-7C0A5B2957AEQ35680402-B6CA84BF-89B7-44ED-B52E-1FDC5ADEDD23Q36146084-A1F01A92-5E78-4654-92FE-854EEDBB94DCQ36755908-85486C2C-A66E-437E-841B-83A3B320A672Q37057865-B81B7D65-9868-4A14-B193-5E122766EFBEQ39079839-64AF1159-D051-4B8D-B6DF-64090F742B58Q39333515-A038194E-D7EA-4FA3-AEEC-5CC811CD190DQ42017209-685C5A88-0EDD-445B-AF66-D5270FA4E037Q42177042-23651876-A33C-485B-B590-B969D3F2FCE6Q42434631-FF2043DF-BF5E-4AAA-BCC9-0E56DA887E3CQ42778503-0AB082AE-D3A7-4628-8CEA-1B67BF3552C9Q43265622-4C6E40D2-3B93-455E-861F-419917403591Q44134659-E5940661-6BF9-4CA5-89AC-EBA8D7158363Q46685294-C8C7DC29-241F-4BBA-A20C-6A017AC33C61Q47161733-5DE7B312-98EF-40B3-9CF1-86E63B8988C4Q47878893-579C0CBF-DAB1-4C44-A018-D555C7859E4AQ48043296-8C298DE5-A763-4CA3-B2E3-07E4DBD69802Q52650242-1FDC8D8A-64DE-465D-AB42-2118646A39B4Q55379831-4CCAC552-8A3C-4226-AACE-15DD57F25D02
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacology of antidepressants.
@ast
Pharmacology of antidepressants.
@en
type
label
Pharmacology of antidepressants.
@ast
Pharmacology of antidepressants.
@en
prefLabel
Pharmacology of antidepressants.
@ast
Pharmacology of antidepressants.
@en
P356
P1476
Pharmacology of antidepressants.
@en
P2093
E Richelson
P304
P356
10.4065/76.5.511
P407
P577
2001-05-01T00:00:00Z